Although Ro52 is largely expressed by immune cells under steady-state conditions (2, 9), its pathogenic relevance in SLE has been centered on keratinocytes, mainly because of the initial association between antibodies against the Ro particle with photosensitivity and cutaneous lupus (10–13). This evidence concerns the gene TRIM21 and systemic lupus erythematosus.